Since it’s quiet on the Bard1 front, I’ve been reading a few pieces on ovarian cancer, Bard1 Irminger-Finger journals, and particularly how our competition fairs currently.
Thought this was the least complicated reading as even I have troubles understanding the science behind our CSO’s previous publications.
http://stopcancerfund.org/p-ovarian-cancer/ovarian-cancer-ca-125-blood-test-does-it-work/
From what I’ve gathered, it will be a big win for not only us but for the female population at risk or currently positive for ovarian cancer.
Imo the ca125 needs to be replaced for something better. So far our Bard1-OC test is showing positive results and thus promising possibilities.
Let’s wait and see as our contribution into this area may have the twofold benefits mentioned above.
Gltah and always dyor.
Ann: Results of BARD1 Ovarian Cancer Study, page-153
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.5¢ |
Change
0.050(8.70%) |
Mkt cap ! $65.94M | |||
| Open | High | Low | Value | Volume |
| 57.5¢ | 63.0¢ | 57.5¢ | $117.5K | 196.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.5¢ | 2484 | 2 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |